97 related articles for article (PubMed ID: 8128170)
1. Prolonged remission of oesophagitis does not alter the magnitude of oesophageal acid exposure.
Singh P; Taylor RH; Colin-Jones DG
Scand J Gastroenterol; 1994 Jan; 29(1):11-6. PubMed ID: 8128170
[TBL] [Abstract][Full Text] [Related]
2. Oesophageal motility and gastro-oesophageal reflux before and after healing of reflux oesophagitis. A study using 24 hour ambulatory pH and pressure monitoring.
Timmer R; Breumelhof R; Nadorp JH; Smout AJ
Gut; 1994 Nov; 35(11):1519-22. PubMed ID: 7828965
[TBL] [Abstract][Full Text] [Related]
3. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis.
Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Aliment Pharmacol Ther; 1988 Jun; 2(3):221-7. PubMed ID: 2979246
[TBL] [Abstract][Full Text] [Related]
4. Oesophageal motor function before and after healing of oesophagitis.
Singh P; Adamopoulos A; Taylor RH; Colin-Jones DG
Gut; 1992 Dec; 33(12):1590-6. PubMed ID: 1487159
[TBL] [Abstract][Full Text] [Related]
5. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
[TBL] [Abstract][Full Text] [Related]
6. Oesophageal function before, during, and after healing of erosive oesophagitis.
Baldi F; Ferrarini F; Longanesi A; Angeloni M; Ragazzini M; Miglioli M; Barbara L
Gut; 1988 Feb; 29(2):157-60. PubMed ID: 3345925
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
Cucchiara S; Minella R; Iervolino C; Franco MT; Campanozzi A; Franceschi M; D'Armiento F; Auricchio S
Arch Dis Child; 1993 Dec; 69(6):655-9. PubMed ID: 8285777
[TBL] [Abstract][Full Text] [Related]
8. Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.
Bianchi Porro G; Pace F; Peracchia A; Bonavina L; Vigneri S; Scialabba A; Franceschi M
J Clin Gastroenterol; 1992 Oct; 15(3):192-8. PubMed ID: 1479161
[TBL] [Abstract][Full Text] [Related]
9. Daytime reduction of gastro-oesophageal reflux after healing of oesophagitis and its value as an indicator of favourable response to maintenance treatment.
Pace F; Sangaletti O; Bianchi Porro G
Gut; 1990 Sep; 31(9):1025-9. PubMed ID: 2210448
[TBL] [Abstract][Full Text] [Related]
10. The effect of healing oesophagitis on oesophageal motor function as determined by oesophageal scintigraphy and ambulatory oesophageal motility/pH monitoring.
McDougall NI; Mooney RB; Ferguson WR; Collins JS; McFarland RJ; Love AH
Aliment Pharmacol Ther; 1998 Sep; 12(9):899-907. PubMed ID: 9768534
[TBL] [Abstract][Full Text] [Related]
11. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.
Klinkenberg-Knol EC; Jansen JM; Festen HP; Meuwissen SG; Lamers CB
Lancet; 1987 Feb; 1(8529):349-51. PubMed ID: 2880161
[TBL] [Abstract][Full Text] [Related]
12. Oesophageal motor response to reflux is not impaired in reflux oesophagitis.
Timmer R; Breumelhof R; Nadorp JH; Smout AJ
Gut; 1993 Mar; 34(3):317-20. PubMed ID: 8472977
[TBL] [Abstract][Full Text] [Related]
13. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
Fiorucci S; Santucci L; Morelli A
Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
[TBL] [Abstract][Full Text] [Related]
14. Alkaline intra-oesophageal pH and gastro-oesophageal reflux in patients with peptic oesophagitis.
Penagini R; Yuen H; Misiewicz JJ; Bianchi PA
Scand J Gastroenterol; 1988 Aug; 23(6):675-8. PubMed ID: 3175530
[TBL] [Abstract][Full Text] [Related]
15. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.
Holloway RH; Dent J; Narielvala F; Mackinnon AM
Gut; 1996 May; 38(5):649-54. PubMed ID: 8707107
[TBL] [Abstract][Full Text] [Related]
16. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
17. Oral ranitidine and duration of gastric pH >4.0 in infants with persisting reflux symptoms.
Salvatore S; Hauser B; Salvatoni A; Vandenplas Y
Acta Paediatr; 2006 Feb; 95(2):176-81. PubMed ID: 16449023
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus.
Parrilla P; Ortiz A; Martinez de Haro LF; Aguayo JL; Ramirez P
Gut; 1990 Sep; 31(9):964-7. PubMed ID: 2210462
[TBL] [Abstract][Full Text] [Related]
19. H2 antagonists in the treatment of reflux oesophagitis: can physiological studies predict the response?
Robertson DA; Aldersley MA; Shepherd H; Lloyd RS; Smith CL
Gut; 1987 Aug; 28(8):946-9. PubMed ID: 3666562
[TBL] [Abstract][Full Text] [Related]
20. Famotidine in the management of acid-reflux oesophagitis: a multicentre study.
Bovero E; Poletti M; Iaquinto G; Giardulo N; Zambelli A; Pisano G; Cheli R
Hepatogastroenterology; 1990 Dec; 37 Suppl 2():145-8. PubMed ID: 2083926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
